Combination therapies and patient stratification with bispecific anti-EGFR/c-Met antibodies | Patent Publication Number 20200270351

US 20200270351 A1
Patent NumberUS 11459391 B2
Application Number16798662
Filled DateFeb 24, 2020
Priority DateFeb 26, 2019
Publication DateAug 27, 2020
Original AssigneeJohnson & Johnson
Current AssigneeJanssen Biotech Inc.
Inventor/ApplicantsSmruthi Vijayaraghavan
Sheri Moores
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.